Connect your AI

Innospec IOSP Repayments of Short-Term Debt

Repayments of Short-Term Debt at other companies

Elevance HealthELV

$150M+30.4%

Boston ScientificBSX

$259M-76.1%

VistraVST

$1.42B—

ChubbCB

$1.92B+329%

Vulcan Materials CompanyVMC

$50M—

McKessonMCK

$6.97B+14.0%

Other financials

Income statement

Revenue$453.2M+2.8%

Gross profit$123.5M-1.3%

Operating income$36.5M-14.1%

Net income$30.4M-7.3%

EPS (diluted)$1.22-6.9%

Balance sheet

Cash & equivalents$289.1M-3.6%

Total debt$50.6M+14.0%

Total equity$1.3B+6.7%

Total assets$1.8B+2.5%

Cash flow

Operating cash flow$17.6M-37.8%

CapEx$8.9M+6.0%

Free cash flow$8.7M-56.3%

Valuation

Market cap$2.05B-23.6%

Profitability

Gross margin27.4%-1.3pp

Operating margin6.9%-2.6pp

Net margin6.4%—

FCF margin4.5%-1.1pp

Returns & leverage

Return on equity8.8%—

Debt / equity0×0.0×

Current ratio3×+0.3×

Where this comes from

Reported directly by Innospec in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfShortTermDebt.

The official record: Innospec’s 10-K, filed February 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innospec's repayments of short-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Innospec's repayments of short-term debt?: Innospec (IOSP) reported repayments of short-term debt of $0 in Q4 2025.